Disc Medicine, Inc.

IRON Healthcare Biotechnology

EPS
+2.53%
Free cash flow
+7.83%
Total debt
+106.5%

Quarter to June 2026, against a year earlier

78.51 0.04 +0.05%
Market cap
$3.5B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Disc Medicine, Inc. (IRON) Book value per share

Alert me on Book value per share

Disc Medicine, Inc.'s book value per share at the end of fiscal 2025 was 21.0×, up 30.4% from 16.1× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 16.7×. Over the past ten years it has ranged from −73.1× (fiscal 2021) to 170× (fiscal 2022); the current reading is higher than 67% of that period. Disc Medicine, Inc. ranks 44th of 611 Biotechnology companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 21.0× 30.45%
FY2024 16.1× 3.90%
FY2023 15.5× (90.90%)
FY2022 170× 0.05%
FY2022 170× —
FY2021 −73.1× —
FY2021 88.4× —
FY2020 −14.5× —
FY2020 −14.5× —

Quarterly newest first

Period Book value per share Change
Jun 2026 16.7× (6.90%)
Mar 2026 17.9× (14.67%)
Dec 2025 21.0× 28.60%
Sep 2025 16.3× (7.05%)
22 more quarters

Against its own ten years

Low −73.1× High 170×
Ten-year median 16.1×
Current reading's percentile 67

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on IRON